Cargando…
Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
Autores principales: | Qiao, H., Wang, T. Y., Yu, Z. F., Han, X. G., Liu, X. Q., Wang, Y. G., Fan, Q. M., Qin, A., Tang, T. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506481/ https://www.ncbi.nlm.nih.gov/pubmed/31068574 http://dx.doi.org/10.1038/s41419-019-1606-1 |
Ejemplares similares
-
Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
por: Qiao, H, et al.
Publicado: (2016) -
Retraction: Intermittent Hypoxia Effect on Osteoclastogenesis Stimulated by Neuroblastoma Cells
Publicado: (2018) -
Retraction: Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis
Publicado: (2020) -
Retraction Note: A natural food sweetener with anti-pancreatic cancer properties
por: Liu, C., et al.
Publicado: (2023) -
Retraction: Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKα-Mediated NF-κB Activation
Publicado: (2019)